This formulation presents the major hyaluronic acid concentration of Evolensys lines (25 MG/ML) and the highest elasto-plasticity properties.
It is indicated to increase the volumes and redefinition of the oval face shape, facial lipoatrophy, chin, and mandibular area with a recommended injection in the deep dermis or shallow subcutaneous tissue.

Technical features

Gel Type                   Monophasic Gel  
HA content                25 mg/ml
Cross-linked agent      BDDE  
Dosage                     1 ml
Needle size               25G Needles TSK
Bacterial Endotoxin     <0.5Eu/mg
Duration                    8-18 months
Certificates                CE 0373, ISO 13485